The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Indacaterol, a once‐daily beta<sub>2</sub>‐agonist, versus twice‐daily beta<sub>2</sub>‐agonists or placebo for chronic obstructive pulmonary disease
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2015
|
| DOI | 10.1002/14651858.cd010139.pub2 |
| Pubmed ID | |
| Authors |
James B Geake, Eli J Dabscheck, Richard Wood‐Baker, Christopher J Cates |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 12 | 38% |
| Grenada | 1 | 3% |
| Portugal | 1 | 3% |
| Venezuela, Bolivarian Republic of | 1 | 3% |
| Greece | 1 | 3% |
| Argentina | 1 | 3% |
| United Kingdom | 1 | 3% |
| United States | 1 | 3% |
| Unknown | 13 | 41% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 20 | 63% |
| Practitioners (doctors, other healthcare professionals) | 9 | 28% |
| Scientists | 2 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 231 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | <1% |
| United States | 1 | <1% |
| Sweden | 1 | <1% |
| Unknown | 227 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 31 | 13% |
| Researcher | 26 | 11% |
| Student > Ph. D. Student | 21 | 9% |
| Student > Bachelor | 21 | 9% |
| Student > Doctoral Student | 13 | 6% |
| Other | 38 | 16% |
| Unknown | 81 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 79 | 34% |
| Nursing and Health Professions | 24 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 4% |
| Social Sciences | 7 | 3% |
| Psychology | 6 | 3% |
| Other | 21 | 9% |
| Unknown | 85 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2024.
All research outputs
#1,282,492
of 26,176,298 outputs
Outputs from Cochrane database of systematic reviews
#2,546
of 13,191 outputs
Outputs of similar age
#16,365
of 361,007 outputs
Outputs of similar age from Cochrane database of systematic reviews
#55
of 282 outputs
Altmetric has tracked 26,176,298 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,191 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.5. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,007 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 282 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.